CUSIP: 654405109
Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
60,741,442
-
Share change
-
+24,341,157
-
Total reported value
-
$52,190,475
-
Put/Call ratio
-
17%
-
Price per share
-
$0.86
-
Number of holders
-
54
-
Value change
-
+$20,945,376
-
Number of buys
-
31
-
Number of sells
-
12
Quarterly Holders Quick Answers
What is CUSIP 654405109?
CUSIP 654405109 identifies NMTR - 9 METERS BIOPHARMA INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2021
-
Previous quarter:
Q3 2020
Recent filing periods for CUSIP 654405109:
Institutional Holders of 9 METERS BIOPHARMA INC - COM (NMTR) as of Q4 2020
As of 31 Dec 2020,
9 METERS BIOPHARMA INC - COM (NMTR) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,741,442 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, AIGH Capital Management LLC, BlackRock Inc., Tri Locum Partners LP, Altium Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, Worth Venture Partners, LLC, and Maven Securities LTD.
This page lists
54
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.